REACT-1 round 9 interim report: downward trend of SARS-CoV-2 in England in February 2021 but still at high prevalence
 Riley, S Walters, C Wang, H Eales, O Haw, D Ainslie, K Atchison, C Fronterre, C Diggle, P Ashby, D Donnelly, C Cooke, G Barclay, W Ward, H Darzi, A Elliott, P
REACT-1 round 11 report: low prevalence of SARS-CoV-2 infection in the community prior to the third step of the English roadmap out of lockdown
 Riley, S Haw, D Walters, C Wang, H Eales, O Ainslie, K Atchison, C Fronterre, C Diggle, P Page, A Trotter, A Le Viet, T Alikhan, N O’Grady, J Consortium, T Ashby, D Donnelly, C Cooke, G Barclay, W Ward, H Darzi, A Elliott, P
REACT-1 round 12 report: resurgence of SARS-CoV-2 infections in England associated with increased frequency of the Delta variant
 Riley, S Wang, H Eales, O Haw, D Walters, C Ainslie, K Atchison, C Fronterre, C Diggle, P Page, A Prosolek, S Trotter, A Le Viet, T Alikhan, N Jackson, L Ludden, C Consortium, T Ashby, D Donnelly, C Cooke, G Barclay, W Ward, H Darzi, A Elliott, P
SARS-CoV-2 lineage dynamics in England from January to March 2021 inferred from representative community samples
 Eales, O Page, A Tang, S Walters, C Wang, H Haw, D Trotter, A Le Viet, T Foster-Nyarko, E Prosolek, S Atchison, C Ashby, D Cooke, G Barclay, W Donnelly, C O’Grady, J Volz, E Consortium, T Darzi, A Ward, H Elliott, P Riley, S
Characterising the persistence of RT-PCR positivity and incidence in a community survey of SARS-CoV-2
 Eales, O Walters, C Wang, H Haw, D Ainslie, K Atchison, C Page, A Prosolek, S Trotter, A Le Viet, T Alikhan, N Jackson, L Ludden, C Consortium, T Ashby, D Donnelly, C Cooke, G Barclay, W Ward, H Darzi, A Elliott, P Riley, S
REACT-1 round 13 interim report: acceleration of SARS-CoV-2 Delta epidemic in the community in England during late June and early July 2021
 Riley, S Eales, O Haw, D Wang, H Walters, C Ainslie, K Atchison, C Fronterre, C Diggle, P Ashby, D Donnelly, C Barclay, W Cooke, G Ward, H Darzi, A Elliott, P
REACT-1 round 13 final report: exponential growth, high prevalence of SARS-CoV-2 and vaccine effectiveness associated with Delta variant in England during May to July 2021
 Elliott, P Haw, D Wang, H Eales, O Walters, C Ainslie, K Atchison, C Fronterre, C Diggle, P Page, A Trotter, A Prosolek, S Consortium, T Ashby, D Donnelly, C Barclay, W Taylor, G Cooke, G Ward, H Darzi, A Riley, S
REACT-1 round 15 interim report: High and rising prevalence of SARS-CoV-2 infection in England from end of September 2021 followed by a fall in late October 2021
 Chadeau-Hyam, M Eales, O Bodinier, B Wang, H Haw, D Whitaker, M Walters, C Atchison, C Diggle, P Page, A Ashby, D Barclay, W Taylor, G Cooke, G Ward, H Darzi, A Donnelly, C Elliott, P
REACT-1 study round 14: High and increasing prevalence of SARS-CoV-2 infection among school-aged children during September 2021 and vaccine effectiveness against infection in England
 Chadeau-Hyam, M Wang, H Eales, O Haw, D Bodinier, B Whitaker, M Walters, C Ainslie, K Atchison, C Fronterre, C Diggle, P Page, A Trotter, A Consortium, T Ashby, D Barclay, W Taylor, G Cooke, G Ward, H Darzi, A Riley, S Donnelly, C Elliott, P
REACT-1 round 15 final report: Increased breakthrough SARS-CoV-2 infections among adults who had received two doses of vaccine, but booster doses and first doses in children are providing important protection
 Chadeau-Hyam, M Eales, O Bodinier, B Wang, H Haw, D Whitaker, M Walters, C Jonnerby, J Atchison, C Diggle, P Page, A Ashby, D Barclay, W Taylor, G Cooke, G Ward, H Darzi, A Donnelly, C Elliott, P
Subscribe to